64 employees
PolyPid offers a technology platform that enables a controlled and prolonged release of any active pharmaceutical ingredients (API).
2008
$15M
from 3 investors over 3 rounds
PolyPid Ltd. raised $15M on April 6, 2022
Investors: Kreos Capital
PolyPid Ltd. raised $8.3M on November 6, 2015
Investors: Guibor and Financière Saint James